Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...

Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target was ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.

Cardinal Health gets downgraded to a hold, from my buy rating last February, agreeing with the Seeking Alpha quant system rating. While macro-level demand for medical supplies is expected to keep ...

By Christy Santhosh and Kamal Choudhury (Reuters) -Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into ...

Citi analyst Daniel Grosslight increased the price target for Cardinal Health (NYSE:CAH) shares to $130 from the previous $129, while keeping a Neutral rating on the stock. The adjustment follows ...

With these words the newly created Philippine Cardinal Pablo Virgilio David y Siongco addressed Pope Francis after finding out that his name appeared among the new cardinals on the list for the ...

Cardinal Christoph Schönborn, OP, concluded his term as archbishop of Vienna, Austria, on Wednesday, his 80th birthday, when Pope Francis accepted his resignation. Schönborn, a theologian who ...

Canadians Cardinal Michael Czerny and sculptor Timothy P. Schmalz on Thursday in Rome spoke about evangelization through art as part of festivities linked to the Jan. 24–26 Jubilee of the World ...

He told the BBC the new complex would be delivered for patients of Cardinal Medical Practice. "You're thinking along the right lines," he said, when pressed on whether the NHS would buy and ...